MicroRNA Molecules Offer Preclinical Clues to Reversing Breast Cancer
A review published in Genes & Diseases suggests that specific microRNA molecules and synthetic RNA inhibitors may improve how breast cancer cells respond to radiotherapy by restoring apoptosis-related mechanisms. The study, conducted by researchers at Mashhad University of Medical Sciences, examines whether modulating these non-coding RNA regulators can counter radiation resistance seen in preclinical models. Radiotherapy damages cancer cells, but some tumors survive by disrupting apoptosis, the intrinsic process that eliminates irreparably damaged cells. The review evaluates laboratory findings from cell lines and animal models, distinguishing microRNAs linked to radiosensitivity from those tied to resistance. It highlights candidates that promote programmed cell death, including miR-200c, which increased radiation sensitivity in breast cancer cell lines, and miR-139-5p, linked to DNA repair and defensive responses.






